Patzer Karl-Heinz, Ardjomand Payam, Göhring Katharina, Klempt Guido, Patzelt Andreas, Redzich Markus, Zebrowski Mathias, Emmerich Susanne, Schnell Oliver
1 Sciarc GmbH, Baierbrunn, Germany.
2 Diabetologische Schwerpunktpraxis, Bergisch Gladbach, Germany.
J Diabetes Sci Technol. 2018 May;12(3):687-694. doi: 10.1177/1932296818759690. Epub 2018 Mar 13.
Medical practices face challenges of time and cost pressures with scarce resources. Point-of-care testing (POCT) has the potential to accelerate processes compared to central laboratory testing and can increase satisfaction of physicians, staff members, and patients. The objective of this study was to evaluate the effects of introducing HbA1c POCT in practices specialized in diabetes.
Three German practices that manage 400, 550, and 950 diabetes patients per year participated in this evaluation. The workflow and required time before and after POCT implementation (device: Alere Afinion AS100 Analyzer) was evaluated in each practice. Physician (n = 5), staff (n = 9), and patient (n = 298) satisfaction was assessed with questionnaires and interviews.
After POCT implementation the number of required visits scheduled was reduced by 80% (88% vs 17.6%, P < .0001), the number of venous blood collections by 75% (91% vs 23%, P < .0001). Of patients, 82% (vs 13% prior to POCT implementation) were able to discuss their HbA1c values with treating physicians immediately during their first visit ( P < .0001). In two of the practices the POCT process resulted in significant time savings of approximately 20 and 22 working days per 1000 patients per year (95% CI 2-46; 95% CI 10-44). All physicians indicated that POCT HbA1c implementation improved the practice workflow and all experienced a relief of burden for the office and the patients. All staff members indicated that they found the POCT measurement easy to perform and experienced a relief of burden. The majority (61.3%) of patients found the capillary blood collection more pleasant and 83% saw an advantage in the immediate availability of HbA1c results.
The implementation of HbA1c POCT leads to an improved practice workflow and increases satisfaction of physicians, staff members and patients.
医疗实践面临着时间和成本压力以及资源稀缺的挑战。与中心实验室检测相比,即时检验(POCT)有可能加快流程,并能提高医生、工作人员和患者的满意度。本研究的目的是评估在糖尿病专科诊所引入糖化血红蛋白(HbA1c)即时检验的效果。
三家每年管理400、550和950名糖尿病患者的德国诊所参与了本评估。在每家诊所评估了POCT实施前后(设备:雅培Afinion AS100分析仪)的工作流程和所需时间。通过问卷调查和访谈评估了医生(n = 5)、工作人员(n = 9)和患者(n = 298)的满意度。
实施POCT后,所需预约就诊次数减少了80%(88%对17.6%,P <.0001),静脉采血次数减少了75%(91%对23%,P <.0001)。82%的患者(与POCT实施前的13%相比)能够在首次就诊时立即与主治医生讨论他们的HbA1c值(P <.0001)。在其中两家诊所,POCT流程每年每1000名患者显著节省约20和22个工作日(95%置信区间2 - 46;95%置信区间10 - 44)。所有医生表示,实施POCT HbA1c改善了诊所工作流程,并且所有人都感受到诊所和患者的负担减轻。所有工作人员表示,他们发现POCT测量易于操作,并且负担减轻。大多数患者(61.3%)认为毛细血管采血更舒适,83%的患者认为HbA1c结果即时可得具有优势。
实施HbA1c POCT可改善诊所工作流程,并提高医生、工作人员和患者的满意度。